|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: Financing
ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield
01.05.2020 / 13:00
ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield
Lausanne, Switzerland, May 1, 2020 ADC Therapeutics SA, a late clinicalstage oncologyfocused biotechnology company pioneering the... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: Personnel
ADC Therapeutics Appoints Victor Sandor, M.D., to Its Board of Directors
27.04.2020 / 13:00
ADC Therapeutics Appoints Victor Sandor, M.D., to Its Board of Directors
Lausanne, Switzerland, April 27, 2020 ADC Therapeutics SA, a late clinicalstage oncologyfocused biotechnology company pioneering the development and... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: IPO
ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering
24.04.2020 / 23:46
ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering
Lausanne, Switzerland April 24, 2020 ADC Therapeutics SA, a late clinicalstage oncologyfocused biotechnology company pioneering the... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: Personnel
ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer
21.04.2020 / 13:00
ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer
Former Celgene executive brings deep oncologyfocused financial expertise as Company prepares for first commercial launch in mid2021 Lausanne, Switzerland, April 21,... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: Personnel
ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company
19.03.2020 / 12:00
ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company
Mr. Squarer, a global biopharmaceutical leader, brings extensive oncology... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: Personnel
ADC Therapeutics Appoints Joseph Camardo, MD, as Head of Medical Affairs
10.01.2020 / 12:00
ADC Therapeutics Appoints Joseph Camardo, MD, as Head of Medical Affairs
Former Celgene and Wyeth leader with 30 years of global biopharmaceutical experience joins company as it prepares for first Biologics License Application... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupNews: ADC Therapeutics SA
/ Key words: Study results
ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine ADCT402 in Patients with Relapsed or Refractory Diffuse Large BCell Lymphoma
09.01.2020 / 12:00
ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent... Lire le communiqué |
|
| |
|
| |
